Related Experiment Video

Updated: Jun 23, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2

N Gammoh1, E Isaacson, V Tomaić

  • 1International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.

Oncogene
|May 8, 2009
PubMed

Insights

Human papillomavirus (HPV) E2 protein controls the oncogenic HPV E7 protein by altering its cell nucleus location. This interaction prevents E7 from causing cell cycle abnormalities and potential transformation.

Area of Science:

  • Oncogenic viral proteins
  • Cell cycle regulation
  • Molecular interactions

Background:

  • Human papillomavirus (HPV) E7 protein drives cell proliferation.
  • HPV E7's transforming potential is linked to its interaction with cellular proteins.
  • Previous work showed HPV E2 can inhibit HPV E7 activity.

Purpose of the Study:

  • To investigate how HPV E2 controls HPV E7 functions.
  • To determine if E2's control over E7 is independent of transcriptional regulation.
  • To elucidate the mechanisms by which E2 inhibits E7's transforming capabilities.

Main Methods:

  • Cellular localization studies of HPV E7.
  • Analysis of pRb protein levels and degradation.
  • Assessment of centrosome abnormalities and mitotic figures.

Main Results:

  • HPV E2 induces a significant re-localization of HPV E7 within the cell nucleus.
  • E2 interaction inhibits E7-mediated degradation of the pRb protein.
  • E2 prevents E7-induced centrosome abnormalities and aberrant mitoses.

Conclusions:

  • HPV E2 plays a critical role in regulating HPV E7's functions.
  • E2 controls E7's impact on cell cycle progression and genomic stability.
  • E2's inhibitory effect on E7 is independent of its transcriptional regulatory role.

More Related Videos

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...